WDB coco Co (TSE:7079) 3-Year Revenue Growth Rate : 17.20% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co 3-Year Revenue Growth Rate?

WDB coco Co's Revenue per Share for the three months ended in Dec. 2023 was 円501.90.

During the past 12 months, WDB coco Co's average Revenue per Share Growth Rate was 9.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of WDB coco Co was 19.10% per year. The lowest was 17.20% per year. And the median was 18.70% per year.

Competitive Comparison of WDB coco Co's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, WDB coco Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WDB coco Co's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where WDB coco Co's 3-Year Revenue Growth Rate falls into.

WDB coco Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

WDB coco Co (TSE:7079) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

WDB coco Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of WDB coco Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines